CATALYST PHARMA PTR
CATALYST PHARMA PTR operates in Diversified Metals & Mining.
CATALYST PHARMA PTR (CN2) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.110x
Based on the latest financial reports, CATALYST PHARMA PTR (CN2) has a cash flow conversion efficiency ratio of 0.110x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€72.87 Million) by net assets (€660.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CATALYST PHARMA PTR - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how CATALYST PHARMA PTR's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CATALYST PHARMA PTR Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CATALYST PHARMA PTR ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hocking Valley Bancshares Inc
PINK:HCKG
|
N/A |
|
GCDL11
SA:GCDL11
|
N/A |
|
Ladenburg Thalmann Financial Se
PINK:LTSH
|
0.050x |
|
Ortel Communications Limited
NSE:ORTEL
|
-0.035x |
|
HORMEL FOODS - Dusseldorf Stock Exchang
DU:HO7
|
0.028x |
|
JUSTSYSTEMS
MU:JSY
|
N/A |
|
BLACKSTONE SECD LEND.FD
F:GM8
|
N/A |
|
Urbanimmersive Inc
PINK:UBMRF
|
-0.002x |
Annual Cash Flow Conversion Efficiency for CATALYST PHARMA PTR (2016–2023)
The table below shows the annual cash flow conversion efficiency of CATALYST PHARMA PTR from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €387.88 Million | €143.60 Million | 0.370x | -4.16% |
| 2022-12-31 | €300.42 Million | €116.05 Million | 0.386x | +32.34% |
| 2021-12-31 | €206.83 Million | €60.37 Million | 0.292x | +9.93% |
| 2020-12-31 | €169.60 Million | €45.03 Million | 0.266x | -32.77% |
| 2019-12-31 | €87.63 Million | €34.61 Million | 0.395x | +178.03% |
| 2018-12-31 | €50.78 Million | €-25.70 Million | -0.506x | -198.20% |
| 2017-12-31 | €80.96 Million | €-13.74 Million | -0.170x | +62.86% |
| 2016-12-31 | €39.31 Million | €-17.96 Million | -0.457x | -- |